Which laboratory tests should be ordered to assess a patient's vitamin status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Assessing Vitamin Status

When assessing vitamin status in patients, order serum vitamin B12 (either total B12 or active B12/holotranscobalamin) and serum 25-hydroxyvitamin D [25(OH)D] only when clinical suspicion exists based on symptoms, signs, or risk factors—not as routine screening in healthy adults.

Vitamin B12 Testing

First-Line Testing Approach

For suspected B12 deficiency, order either total B12 (serum cobalamin) or active B12 (serum holotranscobalamin) as your initial test 1. While active B12 measures the biologically active form available to cells and may be more accurate, the evidence supporting routine use over total B12 is insufficient to justify the significantly higher cost (£18 vs £2 per test) and longer turnaround time 1.

Interpretation Thresholds

  • Total B12 < 180 ng/L (133 pmol/L): Confirmed deficiency
  • Total B12 180-350 ng/L (133-258 pmol/L): Indeterminate—possible deficiency
  • Active B12 < 25 pmol/L: Confirmed deficiency
  • Active B12 25-70 pmol/L: Indeterminate—possible deficiency 1

Confirmatory Testing

When initial B12 results fall in the indeterminate range, consider measuring methylmalonic acid (MMA) as a confirmatory test 1. MMA reflects the functional status of vitamin B12 and provides more reliable diagnosis, though it is expensive (£11-80) and requires specialist equipment 1. Alternatively, homocysteine >20 µmol/L may suggest B12 deficiency in folate-replete patients 2.

Who to Test

Test patients with:

  • Neurological symptoms (peripheral neuropathy, balance issues, cognitive impairment, vision problems)
  • Hematological abnormalities (macrocytic anemia, unexplained fatigue)
  • Risk factors: vegan/vegetarian diet, malabsorption conditions (celiac disease, atrophic gastritis), medications (metformin, PPIs, H2 blockers), autoimmune conditions 1

Vitamin D Testing

Screening Recommendations

Do not routinely screen healthy adults for 25(OH)D levels 3. The 2024 Endocrine Society guideline explicitly recommends against routine screening because outcome-specific benefits of particular 25(OH)D levels have not been established in clinical trials 3.

When to Test

Reserve 25(OH)D testing for patients with:

  • Established indications (hypocalcemia, osteoporosis, malabsorption)
  • Specific clinical conditions requiring monitoring
  • Not for general population screening 3

Empiric Supplementation Strategy

Instead of testing, the guideline recommends empiric vitamin D supplementation (intake exceeding Dietary Reference Intakes without testing) for:

  • Children and adolescents (ages 1-18 years)
  • Adults ≥75 years
  • Pregnant women
  • Individuals with prediabetes 3, 4

Other Vitamins

Vitamin A

Serum or plasma retinol is the most commonly used marker, though it has low sensitivity (0-54%) when compared to reference standards 5. Retinol-binding protein (RBP) is an alternative with moderate specificity (76-98%) but similarly low sensitivity 5. Testing is primarily indicated in populations at high risk for deficiency rather than routine screening.

Vitamin K

PIVKA-II (Protein Induced by Vitamin K Absence) is the preferred functional marker (reference range 17.4-50.9 mAU/mL) 6. Phylloquinone (K1) in serum can be measured (deficiency <0.15 µg/L), but PIVKA-II provides better insight into cellular utilization 6. Primary indications include suspected vitamin K deficiency bleeding in newborns and monitoring anticoagulation.

Folate

Red blood cell folate is preferred over serum folate as it reflects tissue stores 7. However, folate deficiency is uncommon in many populations due to food fortification. In the reviewed data, only 2.4% of folate tests showed deficiency 8, suggesting significant overordering.

Critical Pitfalls to Avoid

  • Avoid indiscriminate testing: Studies show 75% of vitamin B12 tests return normal results, indicating widespread inappropriate ordering 8
  • Don't use PT/INR as a vitamin K status indicator: Coagulation assays lack sensitivity and specificity for this purpose 6
  • Don't order folate routinely with B12: Only 2.4% yield positive results 8
  • Recognize test limitations: Single markers cannot achieve perfect sensitivity or specificity 2, 7
  • Consider functional markers: When abundance markers (serum levels) are indeterminate, functional markers (MMA, homocysteine, PIVKA-II) provide better diagnostic clarity 1, 6, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.